Vinorelbine

Chemical formula: C₄₅H₅₄N₄O₈  Molecular mass: 778.947 g/mol  PubChem compound: 44424639

Therapeutic indications

Vinorelbine is indicated for:

Non small cell lung cancer

Population group: only adults (18 years old or older)

The first line treatment of stage 3 or 4 non small cell lung cancer.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Breast cancer

Population group: only adults (18 years old or older)

The treatment of advanced breast cancer stage 3 and 4 relapsing after or refractory to an anthracycline containing regimen.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Vinorelbine is contraindicated in the following cases:

Disease significantly affecting absorption

Malabsorption syndrome

Lactation

Lactation

Yellow fever vaccines

Yellow fever vaccines

Long-term oxygen therapy

Long-term oxygen therapy

Thrombocytopenia

Thrombocytopenic disorder

Neutropenia, infection

at least one of
Neutropenia
Infectious disease

Surgical resection of stomach or small bowel

at least one of
Gastrectomy
Small intestine excision

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2016: VINORELBINE Concentrate for solution for infusion
Summary of Product Characteristics (SPC) 2019: VINORELBINE Soft capsule
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈